Detection of Telomerase Activity and the Expression of Telomerase Subunits in the Patients with Acute Myelogenous Leukaemia

Telomerase activity and the expression of telomerase subunits (for example, telomerase reverse transcriptase and telomerase associated protein 1 and telomerase RNA component) of peripheral white blood cells were detected in the patients with acute myelogenous leukaemia (AML) and the correlation betw...

Full description

Saved in:
Bibliographic Details
Published inCurrent medical science Vol. 24; no. 1; pp. 48 - 51
Main Author 李一荣 吴健民 王琳 陈凤花 胡丽华
Format Journal Article
LanguageEnglish
Published China Department of Laboratory & Institute of Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Techonology , Wuhan 430022%Li f e Scientific College, Wuhan University, Wuhan 450072%Trans fusion Department, Union Hospital, Tongji Medical College, Huazhong University of Science and Techonology ,Wuhan 430022 2004
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Telomerase activity and the expression of telomerase subunits (for example, telomerase reverse transcriptase and telomerase associated protein 1 and telomerase RNA component) of peripheral white blood cells were detected in the patients with acute myelogenous leukaemia (AML) and the correlation between telomerase activity and the expression of telomerase subunits was observed. In 94 peripheral white blood cells from 18 healthy volunteers and 76 patients with AML,including 31 AML at initial presentation, 24 at relapse and 21 at complete remission, the telomerase activity and telomerase subunits mRNA or RNA were detected by PCR-ELISA and RT-PCR respectively. The results showed that the positive rate of telomerase from patients with AML at initial presentation, at relapse and at complete remission was 74.1%, 79.2% and 4.8% respectively.The positive rate of telomerase reverse transcriptase mRNA from healthy volunteers, AML at initial presentation, AML at relapse and AML at complete remission was 5.6%, 80.6%, 83.3%and 9.5% respectively. The positive rate of telomerase associated protein 1 mRNA and telomerase RNA component in all samples were 100%. It was suggested that the up-regulation of telomerase activity and the expression of telomerase reverse transcriptase is correlated closely with the occurrence and relapse of AML, so telomerase activity and the expression of telomerase reverse transcriptase may be used to estimate the curative effect and predict relapse of AML. Moreover, the upregulation of telomerase activity is correlated with the expression of telomerase reverse transcriptase significantly.
AbstractList Telomerase activity and the expression of telomerase subunits (for example, telomerase reverse transcriptase and telomerase associated protein 1 and telomerase RNA component) of peripheral white blood cells were detected in the patients with acute myelogenous leukaemia (AML) and the correlation between telomerase activity and the expression of telomerase subunits was observed. In 94 peripheral white blood cells from 18 healthy volunteers and 76 patients with AML, including 31 AML at initial presentation, 24 at relapse and 21 at complete remission, the telomerase activity and telomerase subunits mRNA or RNA were detected by PCR-ELISA and RT-PCR respectively. The results showed that the positive rate of telomerase from patients with AML at initial presentation, at relapse and at complete remission was 74.1%, 79.2% and 4.8% respectively. The positive rate of telomerase reverse transcriptase mRNA from healthy volunteers, AML at initial presentation, AML at relapse and AML at complete remission was 5.6%, 80.6%, 83.3% and 9.5% respectively. The positive rate of telomerase associated protein 1 mRNA and telomerase RNA component in all samples were 100%. It was suggested that the up-regulation of telomerase activity and the expression of telomerase reverse transcriptase is correlated closely with the occurrence and relapse of AML, so telomerase activity and the expression of telomerase reverse transcriptase may be used to estimate the curative effect and predict relapse of AML. Moreover, the up-regulation of telomerase activity is correlated with the expression of telomerase reverse transcriptase significantly.
R73; Summary: Telomerase activity and the expression of telomerase subunits (for example, telomerase reverse transcriptase and telomerase associated protein 1 and telomerase RNA component) of peripheral white blood cells were detected in the patients with acute myelogenous leukaemia (AML)and the correlation between telomerase activity and the expression of telomerase subunits was observed. In 94 peripheral white blood cells from 18 healthy volunteers and 76 patients with AML,including 31 AML at initial presentation, 24 at relapse and 21 at complete remission, the telomerase activity and telomerase subunits mRNA or RNA were detected by PCR-ELISA and RT-PCR respectively. The results showed that the positive rate of telomerase from patients with AML at initial presentation, at relapse and at complete remission was 74.1 %, 79.2 % and 4.8 % respectively.The positive rate of telomerase reverse transcriptase mRNA from healthy volunteers, AML at initial presentation, AML at relapse and AML at complete remission was 5.6 %, 80. 6 %, 83.3 %and 9.5 % respectively. The positive rate of telomerase associated protein 1 mRNA and telomerase RNA component in all samples were 100 %. It was suggested that the up-regulation of telomerase activity and the expression of telomerase reverse transcriptase is correlated closely with the occurrence and relapse of AML, so telomerase activity and the expression of telomerase reverse transcriptase may be used to estimate the curative effect and predict relapse of AML. Moreover, the upregulation of telomerase activity is correlated with the expression of telomerase reverse transcriptase significantly.
Telomerase activity and the expression of telomerase subunits (for example, telomerase reverse transcriptase and telomerase associated protein 1 and telomerase RNA component) of peripheral white blood cells were detected in the patients with acute myelogenous leukaemia (AML) and the correlation between telomerase activity and the expression of telomerase subunits was observed. In 94 peripheral white blood cells from 18 healthy volunteers and 76 patients with AML, including 31 AML at initial presentation, 24 at relapse and 21 at complete remission, the telomerase activity and telomerase subunits mRNA or RNA were detected by PCR-ELISA and RT-PCR respectively. The results showed that the positive rate of telomerase from patients with AML at initial presentation, at relapse and at complete remission was 74.1%, 79.2% and 4.8% respectively. The positive rate of telomerase reverse transcriptase mRNA from healthy volunteers, AML at initial presentation, AML at relapse and AML at complete remission was 5.6%, 80.6%, 83.3% and 9.5% respectively. The positive rate of telomerase associated protein 1 mRNA and telomerase RNA component in all samples were 100%. It was suggested that the up-regulation of telomerase activity and the expression of telomerase reverse transcriptase is correlated closely with the occurrence and relapse of AML, so telomerase activity and the expression of telomerase reverse transcriptase may be used to estimate the curative effect and predict relapse of AML. Moreover, the up-regulation of telomerase activity is correlated with the expression of telomerase reverse transcriptase significantly.Telomerase activity and the expression of telomerase subunits (for example, telomerase reverse transcriptase and telomerase associated protein 1 and telomerase RNA component) of peripheral white blood cells were detected in the patients with acute myelogenous leukaemia (AML) and the correlation between telomerase activity and the expression of telomerase subunits was observed. In 94 peripheral white blood cells from 18 healthy volunteers and 76 patients with AML, including 31 AML at initial presentation, 24 at relapse and 21 at complete remission, the telomerase activity and telomerase subunits mRNA or RNA were detected by PCR-ELISA and RT-PCR respectively. The results showed that the positive rate of telomerase from patients with AML at initial presentation, at relapse and at complete remission was 74.1%, 79.2% and 4.8% respectively. The positive rate of telomerase reverse transcriptase mRNA from healthy volunteers, AML at initial presentation, AML at relapse and AML at complete remission was 5.6%, 80.6%, 83.3% and 9.5% respectively. The positive rate of telomerase associated protein 1 mRNA and telomerase RNA component in all samples were 100%. It was suggested that the up-regulation of telomerase activity and the expression of telomerase reverse transcriptase is correlated closely with the occurrence and relapse of AML, so telomerase activity and the expression of telomerase reverse transcriptase may be used to estimate the curative effect and predict relapse of AML. Moreover, the up-regulation of telomerase activity is correlated with the expression of telomerase reverse transcriptase significantly.
Telomerase activity and the expression of telomerase subunits (for example, telomerase reverse transcriptase and telomerase associated protein 1 and telomerase RNA component) of peripheral white blood cells were detected in the patients with acute myelogenous leukaemia (AML) and the correlation between telomerase activity and the expression of telomerase subunits was observed. In 94 peripheral white blood cells from 18 healthy volunteers and 76 patients with AML,including 31 AML at initial presentation, 24 at relapse and 21 at complete remission, the telomerase activity and telomerase subunits mRNA or RNA were detected by PCR-ELISA and RT-PCR respectively. The results showed that the positive rate of telomerase from patients with AML at initial presentation, at relapse and at complete remission was 74.1%, 79.2% and 4.8% respectively.The positive rate of telomerase reverse transcriptase mRNA from healthy volunteers, AML at initial presentation, AML at relapse and AML at complete remission was 5.6%, 80.6%, 83.3%and 9.5% respectively. The positive rate of telomerase associated protein 1 mRNA and telomerase RNA component in all samples were 100%. It was suggested that the up-regulation of telomerase activity and the expression of telomerase reverse transcriptase is correlated closely with the occurrence and relapse of AML, so telomerase activity and the expression of telomerase reverse transcriptase may be used to estimate the curative effect and predict relapse of AML. Moreover, the upregulation of telomerase activity is correlated with the expression of telomerase reverse transcriptase significantly.
Author 李一荣 吴健民 王琳 陈凤花 胡丽华
AuthorAffiliation DepartmentofLaboratory&InstituteofImmunology,UnionHospital,TongjiMedicalCollege,HuazhongUniversityofScienceandTechonology,Wuhan430022 LifeScientificCollege,WuhanUniversity,Wuhan430072 TransfusionDepartment,UnionHospital,TongjiMedicalCollege,HuazhongUniversityofScienceandlechonology,Wuhan430022
AuthorAffiliation_xml – name: Department of Laboratory & Institute of Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Techonology , Wuhan 430022%Li f e Scientific College, Wuhan University, Wuhan 450072%Trans fusion Department, Union Hospital, Tongji Medical College, Huazhong University of Science and Techonology ,Wuhan 430022
Author_xml – sequence: 1
  fullname: 李一荣 吴健民 王琳 陈凤花 胡丽华
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15165114$$D View this record in MEDLINE/PubMed
BookMark eNpt0Utv1DAQAGALtaIPuPADULhwAKX4lTg5tqWFSotAopwt2xnvejdxtrZDd8Wfx2UXKgEnj61vxp7xCTrwoweEXhB8RjAW7y6uMW0YFpg_QcekbVlJWEUPclwLWmLB2BE6iXGJcSVqyp-iI1KRuiKEH6Mf7yGBSW70xWiLW-jHAYKKUJznw-8ubQvluyItoLjarAPE-K_8OunJuxQL53_BLyo58Hl_79Ii15kSFJ-22c_Bj1MsZjCtFAxOPUOHVvURnu_XU_Tt-ur28mM5-_zh5vJ8VhrSUlYCrURlTWeNNjyHAB1npNWNsZa3pgHctbzjuTOuGbO1YMLQRtdcYAq6atgperure6-8VX4ul-MUfL5RpuV21W02WgLFmGOCCcv69U6vw3g3QUxycNFA3ysP-flSkLbiQuAMX-7hpAfo5Dq4QYWt_D3cDPAOmDDGGMBK45J6mHUKyvWSYPnwf_Lx_3LKm79S_lT9H361x4vRz-9c7kwrs7KuB9myuq4rwX4C4Vml3g
CitedBy_id crossref_primary_10_1634_stemcells_2007_0057
crossref_primary_10_1007_s11596_008_0318_z
crossref_primary_10_1038_sj_leu_2404339
crossref_primary_10_1002_gcc_21962
Cites_doi 10.1016/S0022-5347(05)68162-1
10.1073/pnas.91.8.2900
10.1016/S0092-8674(00)80538-3
10.1126/science.277.5328.955
10.1101/SQB.1994.059.01.035
10.1054/bjoc.1999.1008
10.1038/13495
10.1046/j.1365-2141.1998.00969.x
10.1016/S0145-2126(99)00134-4
10.1038/353451a0
ClassificationCodes R73
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.1007/BF02830704
DatabaseName 维普_期刊
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1993-1352
2523-899X
EndPage 51
ExternalDocumentID tjykdxxb_e200401013
15165114
10_1007_BF02830704
9366657
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: 湖北省科技厅科研项目
  funderid: (2002AA304B10)
GroupedDBID -5E
-5G
-BR
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
29K
29~
2B.
2C~
2J2
2JN
2KG
2KM
2LR
2RA
2~H
30V
4.4
408
40D
40E
53G
5GY
5VS
6NX
8TC
8UJ
92F
92I
92L
95-
95.
95~
96X
AAAVM
AABHQ
AAJKR
AANXM
AARHV
AARTL
AAYIU
AAYQN
AAYTO
ABFTV
ABJOX
ABKCH
ABMNI
ABNWP
ABQBU
ABTMW
ACGFS
ACHXU
ACKNC
ACOMO
ACSNA
ACUDM
ADHIR
ADINQ
ADKPE
ADURQ
ADYFF
ADZKW
AEBTG
AEGNC
AEJHL
AEKMD
AEOHA
AEPYU
AETLH
AEXYK
AFWTZ
AFZKB
AGAYW
AGDGC
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHYZX
AIIXL
AJBLW
AJRNO
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
ARMRJ
AZFZN
B-.
BA0
BGNMA
CAG
CCEZO
CHBEP
CIEJG
COF
CQIGP
CS3
CSCUP
CW9
D-I
EBS
EJD
ESBYG
FA0
FEDTE
FNLPD
FRRFC
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GQ6
GQ7
H13
HF~
HG6
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IPNFZ
IXD
I~X
I~Z
J-C
JBSCW
JUIAU
KOV
M4Y
MA-
N2Q
NDZJH
NQJWS
NU0
O9-
O93
O9I
O9J
P9S
PF0
QOR
QOS
R-E
R89
R9I
RIG
ROL
RPX
RSV
S..
S16
S1Z
S27
S37
S3B
SAP
SCL
SDH
SHX
SMD
SNE
SNX
SOJ
SPISZ
SZ9
SZN
T13
TCJ
TGQ
TSG
TT1
TUC
U2A
U9L
UG4
VC2
W48
W91
WK8
Z7U
Z82
Z8V
ZOVNA
~A9
~WA
-05
-0E
-SE
-S~
2JY
406
5VR
92M
9D9
9DE
AACDK
AAHNG
AAIAL
AAJBT
AANZL
AAPKM
AASML
AATNV
AAUYE
AAYXX
AAYZH
ABAKF
ABBRH
ABDBE
ABDZT
ABECU
ABFSG
ABHQN
ABJNI
ABKZE
ABMQK
ABSXP
ABTEG
ABTKH
ABWNU
ABXPI
ACAOD
ACDTI
ACHSB
ACMDZ
ACMLO
ACOKC
ACSTC
ACZOJ
ADKNI
ADRFC
ADTPH
AEFQL
AEJRE
AEMSY
AESKC
AEVLU
AEZWR
AFBBN
AFDZB
AFHIU
AFLOW
AFOHR
AFQWF
AFUIB
AGJBK
AGMZJ
AGQEE
AGRTI
AHPBZ
AHSBF
AHWEU
AIAKS
AIGIU
AILAN
AITGF
AIXLP
AMXSW
AMYLF
AMYQR
AOCGG
ATHPR
AXYYD
AYFIA
BDATZ
CAJEE
CITATION
DDRTE
DNIVK
DPUIP
EBLON
EIOEI
FERAY
FFXSO
FIGPU
FINBP
FSGXE
GNWQR
GRRUI
IKXTQ
IWAJR
JZLTJ
LLZTM
NPVJJ
PT4
Q--
RHV
RT5
SCLPG
SDE
SISQX
SJYHP
SNPRN
SOHCF
SRMVM
SSLCW
STPWE
T8U
U1F
U1G
U5E
U5O
UOJIU
UTJUX
UZXMN
VFIZW
YLTOR
ZMTXR
ABQSL
ADHKG
CGR
CUY
CVF
ECM
EIF
NPM
7X8
AGQPQ
4A8
93N
PSX
ID FETCH-LOGICAL-c1923-e2575fcdfcbc4575eed4319b8cff49c8e0d94d46244b33f6737c28b64702eb583
ISSN 1672-0733
2096-5230
IngestDate Thu May 29 04:06:47 EDT 2025
Fri Jul 11 05:08:43 EDT 2025
Thu Apr 03 07:08:33 EDT 2025
Tue Jul 01 04:14:33 EDT 2025
Thu Apr 24 22:57:08 EDT 2025
Thu Nov 24 20:34:23 EST 2022
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords telomerase RNA component
telomerase
telomerase reverse transcriptase
telomerase associated protein 1
acute myelogenous leukaemia
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1923-e2575fcdfcbc4575eed4319b8cff49c8e0d94d46244b33f6737c28b64702eb583
Notes 42-1679/R
R733.71
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 15165114
PQID 71954770
PQPubID 23479
PageCount 4
ParticipantIDs wanfang_journals_tjykdxxb_e200401013
proquest_miscellaneous_71954770
pubmed_primary_15165114
crossref_citationtrail_10_1007_BF02830704
crossref_primary_10_1007_BF02830704
chongqing_backfile_9366657
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2004-00-00
PublicationDateYYYYMMDD 2004-01-01
PublicationDate_xml – year: 2004
  text: 2004-00-00
PublicationDecade 2000
PublicationPlace China
PublicationPlace_xml – name: China
PublicationTitle Current medical science
PublicationTitleAlternate Journal of Zuazhong University of Science and Technology: Medical Edition
PublicationTitle_FL JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY(MEDICAL SCIENCES)
PublicationYear 2004
Publisher Department of Laboratory & Institute of Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Techonology , Wuhan 430022%Li f e Scientific College, Wuhan University, Wuhan 450072%Trans fusion Department, Union Hospital, Tongji Medical College, Huazhong University of Science and Techonology ,Wuhan 430022
Publisher_xml – name: Department of Laboratory & Institute of Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Techonology , Wuhan 430022%Li f e Scientific College, Wuhan University, Wuhan 450072%Trans fusion Department, Union Hospital, Tongji Medical College, Huazhong University of Science and Techonology ,Wuhan 430022
References B Ivan (BF02830704_CR6) 2000; 6
C M Counter (BF02830704_CR7) 1994; 91
A K Barbara (BF02830704_CR5) 1999; 23
C B Harley (BF02830704_CR8) 1994; 59
X Dawei (BF02830704_CR11) 1998; 102
N Toshikuni (BF02830704_CR12) 2000; 82
L A Harrington (BF02830704_CR10) 1991; 353
J Flint (BF02830704_CR9) 1994; 55
S Tohru (BF02830704_CR4) 1999; 162
T M Nakamura (BF02830704_CR1) 1997; 277
W C Hahn (BF02830704_CR3) 1999; 5
M Meyerson (BF02830704_CR2) 1997; 90
References_xml – volume: 162
  start-page: 2217
  year: 1999
  ident: BF02830704_CR4
  publication-title: J Urol
  doi: 10.1016/S0022-5347(05)68162-1
– volume: 91
  start-page: 2900
  year: 1994
  ident: BF02830704_CR7
  publication-title: Proc Nat Acad Sci
  doi: 10.1073/pnas.91.8.2900
– volume: 90
  start-page: 785
  year: 1997
  ident: BF02830704_CR2
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)80538-3
– volume: 6
  start-page: 452
  year: 2000
  ident: BF02830704_CR6
  publication-title: Clin Can Res
– volume: 277
  start-page: 955
  year: 1997
  ident: BF02830704_CR1
  publication-title: Science
  doi: 10.1126/science.277.5328.955
– volume: 59
  start-page: 307
  year: 1994
  ident: BF02830704_CR8
  publication-title: Cold Spring Harb Symp Quant Biol
  doi: 10.1101/SQB.1994.059.01.035
– volume: 82
  start-page: 833
  year: 2000
  ident: BF02830704_CR12
  publication-title: Br J Cancer
  doi: 10.1054/bjoc.1999.1008
– volume: 5
  start-page: 1164
  year: 1999
  ident: BF02830704_CR3
  publication-title: Nature Medicine
  doi: 10.1038/13495
– volume: 102
  start-page: 1367
  year: 1998
  ident: BF02830704_CR11
  publication-title: Br J Haematol
  doi: 10.1046/j.1365-2141.1998.00969.x
– volume: 55
  start-page: 505
  year: 1994
  ident: BF02830704_CR9
  publication-title: Am J Hum Genet
– volume: 23
  start-page: 1097
  year: 1999
  ident: BF02830704_CR5
  publication-title: Leukemia Res
  doi: 10.1016/S0145-2126(99)00134-4
– volume: 353
  start-page: 451
  year: 1991
  ident: BF02830704_CR10
  publication-title: Nature
  doi: 10.1038/353451a0
SSID ssj0057624
ssib031263182
ssj0002039635
ssib051367596
ssib034325102
Score 1.5726589
Snippet Telomerase activity and the expression of telomerase subunits (for example, telomerase reverse transcriptase and telomerase associated protein 1 and telomerase...
R73; Summary: Telomerase activity and the expression of telomerase subunits (for example, telomerase reverse transcriptase and telomerase associated protein 1...
SourceID wanfang
proquest
pubmed
crossref
chongqing
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 48
SubjectTerms Carrier Proteins - metabolism
Child
DNA-Binding Proteins
ELISA
Humans
Leukemia, Myeloid, Acute - enzymology
Reverse Transcriptase Polymerase Chain Reaction
RNA - metabolism
RNA, Messenger - metabolism
RNA-Binding Proteins
Telomerase - metabolism
急性髓性白血病
核蛋白聚合酶
端粒酶亚型
端粒酶活性
聚合酶链反应
Title Detection of Telomerase Activity and the Expression of Telomerase Subunits in the Patients with Acute Myelogenous Leukaemia
URI http://lib.cqvip.com/qk/85740A/20041/9366657.html
https://www.ncbi.nlm.nih.gov/pubmed/15165114
https://www.proquest.com/docview/71954770
https://d.wanfangdata.com.cn/periodical/tjykdxxb-e200401013
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLfKduGCQHx1wLDELhwytYnzdezGqgqVcmmlcopsx966tinQROrGgX-d9xI7TdchPi5R5DpO6t9Pz8_28-8RctIRXQ4_dB2hdOowrVIncrnrKKUjP2YBF-V2wadRMJiwj1N_2mr9bEQtFbk4lbf3niv5H1ShDHDFU7L_gGzdKBTAPeALV0AYrn-F8QeVK2ldvlwtVrjCtK4EMsqcEDY8Um1MvOvdmutCFBnuHZhwRyOzas-8SYwiWN5AfaPlulDFnKvljP_GqR0U_PYK0xftBnxYC4Lfs13MP623icw4XPv3wzLG4Asewbush42iZBzQeTlrlJr17uGsZvm5OXACUF1eFXxnXYM1jHAQYkRsJZBhrbTL9thYmdxKqHNvJOjY-HZUOAtN8zty26PPSX8yHCbji-n4ATl0YZ6BKTAmbs8O5TAXq7Ii2w_a1bc1LaMqB_bsN_jzu97N3pSlPBmWaeiZhhMzfkweGaBor6LSE9JS2VPyo6YRXWm6JQe1NKIAGwV20C2N7tS0NKKzrKxoaUSRRrSkEW3QiNY0ekYm_Yvx-cAxOTkciXMBR4GJ97VMtRSSwS24WOCCxiKSWrNYRqqTxixl0G9MeJ7GLEjSjUTAwo6rhB95z8lBtsrUS0Jj7jPBUy6VC4_oOGZxymGE1l0dK0_zNjmq-xV8OjlHpbIk9gLcLGyT97ajE2nU7DGpyiKxOtxbgNrkXV33a6Xhcm-ttxavBEws7pvxTEGfJCGqIoZhp01eVDBuW_G7AcxY4NkTg2tizMM6ya9v5ulmIxKF7EYpR-_oj694RR5WoWG4xveaHOTfC_UGvN5cHJPDXv_sbHRcMvQXGWq5vQ
linkProvider Springer Nature
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Detection+of+telomerase+activity+and+the+expression+of+telomerase+subunits+in+the+patients+with+acute+myelogenous+leukaemia&rft.jtitle=Journal+of+Huazhong+University+of+Science+and+Technology.+Medical+sciences&rft.au=Li%2C+Yirong&rft.au=Wu%2C+Jianming&rft.au=Wang%2C+Lin&rft.au=Chen%2C+Fenghua&rft.date=2004&rft.issn=1672-0733&rft.volume=24&rft.issue=1&rft.spage=48&rft_id=info:doi/10.1007%2FBF02830704&rft.externalDBID=NO_FULL_TEXT
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85740A%2F85740A.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Ftjykdxxb-e%2Ftjykdxxb-e.jpg